Insulet Corp $ 293.14 (3.05%)
Volume:
336,888
Avg Vol (1m):
482,581
Market Cap $:
19.33 Bil
Enterprise Value $:
19.36 Bil
P/E (TTM):
666.23
P/B:
32.45
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 0.96 | ||
Equity-to-Asset | 0.35 | ||
Debt-to-Equity | 1.56 | ||
Debt-to-EBITDA | 7.9 | ||
Interest Coverage | 1.77 | ||
Piotroski F-Score | 5 | ||
Altman Z-Score | 10.9 | ||
Beneish M-Score | -2.56 | ||
WACC vs ROIC |
Profitability Rank | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | 8.86 | ||
Net Margin % | 3.33 | ||
ROE % | 10.01 | ||
ROA % | 2.11 | ||
ROC (Joel Greenblatt) % | 16.03 | ||
3-Year Revenue Growth Rate | 22.7 | ||
3-Year EBITDA Growth Rate | 262.5 |
PODD
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PE Ratio | 666.23 | ||
Forward PE Ratio | 251.34 | ||
PE Ratio without NRI | 666.23 | ||
PB Ratio | 32.45 | ||
PS Ratio | 21.91 | ||
Price-to-Operating-Cash-Flow | 145.9 | ||
EV-to-EBIT | 246.93 | ||
EV-to-EBITDA | 165.18 | ||
EV-to-Revenue | 22.3 | ||
Current Ratio | 6.62 | ||
Quick Ratio | 5.91 | ||
Days Inventory | 120.46 | ||
Days Sales Outstanding | 35.92 | ||
Days Payable | 66.6 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -2.9 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 35.45 | ||
Price-to-Median-PS-Value | 2.73 | ||
Price-to-Graham-Number | 32.36 | ||
Earnings Yield (Greenblatt) % | 0.43 |